Section R386-702-16 - Special Measures to Prevent Perinatal and Person-to-Person Transmission of Hepatitis B Infection(1) A licensed healthcare provider who provides prenatal care shall routinely test each pregnant woman for hepatitis B surface antigen (HBsAg) at an early prenatal care visit. This section does not apply if the pregnant woman, after being informed of the possible consequences, objects to the test on the basis of religious or personal beliefs.(2) The licensed healthcare provider who provides prenatal care shall repeat the HBsAg test during late pregnancy for those women who tested negative for HBsAg during early pregnancy, but who are at high risk based on: (a) evidence of clinical hepatitis during pregnancy;(c) occurrence during pregnancy or a history of a sexually transmitted disease;(d) occurrence of hepatitis B in a household or close family contact; or(e) the judgment of the healthcare provider.(3) In addition to other reporting required by this rule, each positive HBsAg result detected in a pregnant woman shall be reported to the local health department or the Department, as specified in Section 26B-7-206. That report shall state that the woman was pregnant at time of testing if that information is available to the reporting entity.(4) A licensed healthcare provider who provides prenatal care shall document a woman's HBsAg test results, or the basis of the objection to the test, in the medical record for that patient.(5) Every hospital and birthing facility shall develop a policy to assure that: (a) when a pregnant woman is admitted for delivery, or for monitoring of pregnancy status, the result from a test for HBsAg performed on that woman during that pregnancy is available for review and documented in the hospital record;(b) when a pregnant woman is admitted for delivery, if the woman's test result is not available to the hospital or birthing facility, the mother is tested for HBsAg as soon as possible, but before discharge from the hospital or birthing facility;(c) if a pregnant woman who has not had prenatal care during that pregnancy is admitted for monitoring of pregnancy status only, and if the woman's test result is not available to the hospital or birthing facility, the mother is tested for HBsAg status before discharge from the hospital or birthing facility;(d) positive HBsAg results identified by testing performed or documented during the hospital stay are reported as specified in this rule;(e) infants born to HBsAg positive mothers receive hepatitis B immune globulin (HBIG) and hepatitis B vaccine, administered at separate injection sites, within 12 hours of birth;(f) infants born to mothers whose HBsAg status is unknown receive hepatitis B vaccine within 12 hours of birth, and if the infant is born preterm with birth weight less than 2,000 grams, that infant also receives HBIG within 12 hours;(g) if at the time of birth the mother's HBsAg status is unknown and the HBsAg test result is later determined to be positive, that infant receives HBIG as soon as possible but within 7 days of birth; and(h) HBIG administration and birth dose hepatitis B vaccine status of infants born to mothers who are HBsAg positive are reported within 24 hours of delivery to the local health department and Utah Department of Health and Human Services Immunization Program at (801) 538-9450.(6) Local health departments shall perform the following activities or assure that they are performed: (a) Females between the ages of 12 and 50 years when an HBsAg positive test result is reported will be screened for pregnancy status within one week of receipt of that lab result.(b) Infants born to HBsAg positive mothers complete the hepatitis B vaccine series as specified in the "Red Book: 2021-2024 Report of the Committee on Infectious Diseases" 32nd Edition. Elk Grove Village, IL, American Academy of Pediatrics; 2021.(c) Children born to HBsAg positive mothers are tested for HBsAg and antibody against hepatitis B surface antigen (anti-HBs) at 9 to 12 months of age to monitor the success of therapy and identify cases of perinatal hepatitis B infection. Testing is done at least one month after the final dose of hepatitis B vaccine series is administered, and no earlier than 9 months of age. Children who test negative for HBsAg and do not demonstrate serological evidence of immunity against hepatitis B when tested as described in this subsection receive three additional vaccine doses and are retested as specified in the "Red Book: 2021-2024 Report of the Committee on Infectious Diseases" 32nd Edition. Elk Grove Village, IL, American Academy of Pediatrics; 2021.(d) HBsAg positive mothers are advised regarding how to reduce their risk of transmitting hepatitis B to others.(e) Household members and sex partners of HBsAg positive mothers are evaluated to determine susceptibility to hepatitis B infection and if determined to be susceptible, are offered or advised to obtain vaccination against hepatitis B. Identified acute hepatitis B cases shall be investigated by the local health department, and identified household and sexual contacts shall be advised to obtain vaccination against hepatitis B.(7) Subsections (5) and (6) do not apply if the pregnant woman or the child's guardian, after being informed of the possible consequences, objects to any of the required procedures on the basis of religious or moral beliefs. The hospital or birthing facility shall document the basis of the objection.(8) Prevention of transmission by individuals with chronic hepatitis B infection.(a) The Department defines a chronic hepatitis B case as a person that is HBsAg positive, total antibody against hepatitis B core antigen (anti-HBc) positive, if performed, and IgM anti-HBc negative.(b) An individual with chronic hepatitis B infection shall be advised regarding how to reduce the risk that the individual will transmit hepatitis B to others.(c) Household members and sex partners of individuals with chronic hepatitis B infection shall be evaluated to determine susceptibility to hepatitis B infection, and if determined to be susceptible, shall be offered or advised to obtain vaccination against Hepatitis B.Utah Admin. Code R386-702-16
Adopted by Utah State Bulletin Number 2017-4, effective 1/27/2017Amended by Utah State Bulletin Number 2018-2, effective 1/2/2018Amended by Utah State Bulletin Number 2019-22, effective 11/1/2019Amended by Utah State Bulletin Number 2020-18, effective 9/8/2020Amended by Utah State Bulletin Number 2023-07, effective 3/14/2023Amended by Utah State Bulletin Number 2024-05, effective 2/12/2024, exp. 6/11/2024 (Emergency)Amended by Utah State Bulletin Number 2024-11, effective 5/29/2024